HLB’s Rivoceranib anti-cancer drug recently received approval in China as a treatment for ovarian cancer, paving the way for the company to expand the drug s uses in the global market, the company said Monday.
Berkshire Hills Bancorp (NYSE:BHLB – Get Free Report) announced its quarterly earnings data on Thursday. The savings and loans company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02, Briefing.com reports. The company had revenue of $169.32 million for the quarter, compared to analysts’ expectations of $107.89 […]
Berkshire Hills Bancorp (NYSE:BHLB – Get Free Report) issued its quarterly earnings results on Thursday. The savings and loans company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.02, Briefing.com reports. Berkshire Hills Bancorp had a return on equity of 8.77% and a net margin of 3.40%. […]
Berkshire Hills Bancorp (NYSE:BHLB – Get Free Report) issued its earnings results on Thursday. The savings and loans company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.47 by $0.02, Briefing.com reports. Berkshire Hills Bancorp had a return on equity of 9.48% and a net margin of 11.24%. During the same period […]
StockNews.com downgraded shares of Berkshire Hills Bancorp (NYSE:BHLB – Free Report) from a hold rating to a sell rating in a report released on Thursday morning. Several other analysts also recently issued reports on the stock. Royal Bank of Canada reissued a sector perform rating and set a $26.00 target price on shares of Berkshire […]